• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙库巴曲通过抑制瞬时受体电位M7通道减轻心脏纤维化。

Sacubitril Ameliorates Cardiac Fibrosis Through Inhibiting TRPM7 Channel.

作者信息

Jia Tian, Wang Xiaozhi, Tang Yiqun, Yu Wenying, Li Chenhui, Cui Shufang, Zhu Juanjuan, Meng Wei, Wang Chen, Wang Quanyi

机构信息

State Key Laboratory of Natural Medicines, Department of Life Sciences and Technology, China Pharmaceutical University, Nanjing, China.

Department of Cardiology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China.

出版信息

Front Cell Dev Biol. 2021 Oct 29;9:760035. doi: 10.3389/fcell.2021.760035. eCollection 2021.

DOI:10.3389/fcell.2021.760035
PMID:34778271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8586221/
Abstract

Heart failure caused by cardiac fibrosis has become a major challenge of public health worldwide. Cardiomyocyte programmed cell death (PCD) and activation of fibroblasts are crucial pathological features, both of which are associated with aberrant Ca influx. Transient receptor potential cation channel subfamily M member 7 (TRPM7), the major Ca permeable channel, plays a regulatory role in cardiac fibrosis. In this study, we sought to explore the mechanistic details for sacubitril, a component of sacubitril/valsartan, in treating cardiac fibrosis. We demonstrated that sacubitril/valsartan could effectively ameliorate cardiac dysfunction and reduce cardiac fibrosis induced by isoprotereno (ISO) . We further investigated the anti-fibrotic effect of sacubitril in fibroblasts. LBQ657, the metabolite of sacubitril, could significantly attenuate transforming growth factor-β 1 (TGF-β1) induced cardiac fibrosis by blocking TRPM7 channel, rather than suppressing its protein expression. In addition, LBQ657 reduced hypoxia-induced cardiomyocyte PCD suppression of Ca influx regulated by TRPM7. These findings suggested that sacubitril ameliorated cardiac fibrosis by acting on both fibroblasts and cardiomyocytes through inhibiting TRPM7 channel.

摘要

由心脏纤维化引起的心力衰竭已成为全球公共卫生面临的一项重大挑战。心肌细胞程序性细胞死亡(PCD)和成纤维细胞的激活是关键的病理特征,二者均与异常的钙内流有关。瞬时受体电位阳离子通道M亚家族成员7(TRPM7)作为主要的钙通透通道,在心脏纤维化中发挥调节作用。在本研究中,我们试图探究沙库巴曲缬沙坦的成分之一沙库巴曲治疗心脏纤维化的具体机制。我们证明,沙库巴曲缬沙坦可有效改善心脏功能障碍,并减轻异丙肾上腺素(ISO)诱导的心脏纤维化。我们进一步研究了沙库巴曲对成纤维细胞的抗纤维化作用。沙库巴曲的代谢产物LBQ657可通过阻断TRPM7通道,而非抑制其蛋白表达,显著减轻转化生长因子-β1(TGF-β1)诱导的心脏纤维化。此外,LBQ657可减少缺氧诱导的心肌细胞PCD,抑制由TRPM7调节的钙内流。这些发现表明,沙库巴曲通过抑制TRPM7通道作用于成纤维细胞和心肌细胞,从而改善心脏纤维化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a90/8586221/244cc9011f26/fcell-09-760035-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a90/8586221/37a6713f2072/fcell-09-760035-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a90/8586221/e3b790a3cf2c/fcell-09-760035-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a90/8586221/e23eb7d2c816/fcell-09-760035-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a90/8586221/244cc9011f26/fcell-09-760035-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a90/8586221/37a6713f2072/fcell-09-760035-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a90/8586221/e3b790a3cf2c/fcell-09-760035-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a90/8586221/e23eb7d2c816/fcell-09-760035-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a90/8586221/244cc9011f26/fcell-09-760035-g005.jpg

相似文献

1
Sacubitril Ameliorates Cardiac Fibrosis Through Inhibiting TRPM7 Channel.沙库巴曲通过抑制瞬时受体电位M7通道减轻心脏纤维化。
Front Cell Dev Biol. 2021 Oct 29;9:760035. doi: 10.3389/fcell.2021.760035. eCollection 2021.
2
Transient receptor potential melastatin 7 (TRPM7) contributes to H2O2-induced cardiac fibrosis via mediating Ca(2+) influx and extracellular signal-regulated kinase 1/2 (ERK1/2) activation in cardiac fibroblasts.瞬时受体电位褪黑素7(TRPM7)通过介导心肌成纤维细胞中的Ca(2+)内流和细胞外信号调节激酶1/2(ERK1/2)激活,促进H2O2诱导的心脏纤维化。
J Pharmacol Sci. 2014;125(2):184-92. doi: 10.1254/jphs.13224fp. Epub 2014 May 28.
3
TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation.TRPM7 介导的 Ca2+ 信号赋予人类心房颤动中的纤维化。
Circ Res. 2010 Mar 19;106(5):992-1003. doi: 10.1161/CIRCRESAHA.109.206771. Epub 2010 Jan 14.
4
AstragalosideⅣ against cardiac fibrosis by inhibiting TRPM7 channel.黄芪甲苷通过抑制 TRPM7 通道抗心脏纤维化。
Phytomedicine. 2017 Jul 1;30:10-17. doi: 10.1016/j.phymed.2017.04.002. Epub 2017 Apr 19.
5
Protective Effects of Sacubitril/Valsartan on Cardiac Fibrosis and Function in Rats With Experimental Myocardial Infarction Involves Inhibition of Collagen Synthesis by Myocardial Fibroblasts Through Downregulating TGF-β1/Smads Pathway.沙库巴曲缬沙坦对实验性心肌梗死大鼠心脏纤维化和功能的保护作用涉及通过下调TGF-β1/Smads信号通路抑制心肌成纤维细胞胶原蛋白合成。
Front Pharmacol. 2021 May 31;12:696472. doi: 10.3389/fphar.2021.696472. eCollection 2021.
6
TRPM7 is involved in angiotensin II induced cardiac fibrosis development by mediating calcium and magnesium influx.瞬时受体电位阳离子通道亚家族M成员7(TRPM7)通过介导钙和镁内流参与血管紧张素II诱导的心脏纤维化发展。
Cell Calcium. 2014 May;55(5):252-60. doi: 10.1016/j.ceca.2014.02.019. Epub 2014 Mar 11.
7
MicroRNA-135a inhibits cardiac fibrosis induced by isoproterenol via TRPM7 channel.微小 RNA-135a 通过 TRPM7 通道抑制异丙肾上腺素诱导的心肌纤维化。
Biomed Pharmacother. 2018 Aug;104:252-260. doi: 10.1016/j.biopha.2018.04.157. Epub 2018 May 25.
8
Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-β/Smads pathway.黄芪甲苷通过 miR-135a-TRPM7-TGF-β/Smads 通路抑制心脏纤维化。
J Ethnopharmacol. 2020 Mar 1;249:112404. doi: 10.1016/j.jep.2019.112404. Epub 2019 Nov 15.
9
Endotoxin induces fibrosis in vascular endothelial cells through a mechanism dependent on transient receptor protein melastatin 7 activity.内毒素通过一种依赖瞬时受体蛋白褪黑素7活性的机制诱导血管内皮细胞纤维化。
PLoS One. 2014 Apr 7;9(4):e94146. doi: 10.1371/journal.pone.0094146. eCollection 2014.
10
Role of TRPM7 in cardiac fibrosis: A potential therapeutic target (Review).瞬时受体电位通道M7(TRPM7)在心脏纤维化中的作用:一个潜在的治疗靶点(综述)
Exp Ther Med. 2021 Feb;21(2):173. doi: 10.3892/etm.2020.9604. Epub 2020 Dec 27.

引用本文的文献

1
Endomyocardial fibrosis: recent advances and future therapeutic targets.心内膜心肌纤维化:最新进展与未来治疗靶点
Nat Rev Cardiol. 2025 Feb 26. doi: 10.1038/s41569-025-01138-x.
2
Consequences of Amyloid-β Deficiency for the Liver.淀粉样蛋白-β缺乏对肝脏的影响。
Adv Sci (Weinh). 2024 May;11(18):e2307734. doi: 10.1002/advs.202307734. Epub 2024 Mar 2.
3
TRPM7 mediates endoplasmic reticulum stress and ferroptosis in sepsis-induced myocardial injury.TRPM7 在脓毒症诱导的心肌损伤中的内质网应激和铁死亡中起介导作用。

本文引用的文献

1
Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy.黄芪甲苷IV通过抑制自噬减轻阿霉素所致的心肌损伤。
Front Pharmacol. 2021 May 24;12:669782. doi: 10.3389/fphar.2021.669782. eCollection 2021.
2
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.心脏病与中风统计-2021 更新:美国心脏协会报告。
Circulation. 2021 Feb 23;143(8):e254-e743. doi: 10.1161/CIR.0000000000000950. Epub 2021 Jan 27.
3
A decade of cell death studies: Breathing new life into necroptosis.
J Bioenerg Biomembr. 2023 Jun;55(3):207-217. doi: 10.1007/s10863-023-09968-5. Epub 2023 Jun 2.
4
The history and mystery of sacubitril/valsartan: From clinical trial to the real world.沙库巴曲缬沙坦的历史与奥秘:从临床试验到现实世界
Front Cardiovasc Med. 2023 Mar 28;10:1102521. doi: 10.3389/fcvm.2023.1102521. eCollection 2023.
5
Cardiovascular toxicity of tyrosine kinase inhibitors during cancer treatment: Potential involvement of TRPM7.癌症治疗期间酪氨酸激酶抑制剂的心血管毒性:TRPM7的潜在作用。
Front Cardiovasc Med. 2023 Feb 3;10:1002438. doi: 10.3389/fcvm.2023.1002438. eCollection 2023.
6
The impact of sacubitril/valsartan on outcome in patients suffering from heart failure with a concomitant diabetes mellitus.沙库巴曲缬沙坦对合并糖尿病心力衰竭患者结局的影响。
ESC Heart Fail. 2023 Apr;10(2):943-954. doi: 10.1002/ehf2.14239. Epub 2022 Dec 7.
7
Emerging role of transient receptor potential (TRP) ion channels in cardiac fibroblast pathophysiology.瞬时受体电位(TRP)离子通道在心脏成纤维细胞病理生理学中的新作用。
Front Physiol. 2022 Oct 6;13:968393. doi: 10.3389/fphys.2022.968393. eCollection 2022.
8
Emerging Antiarrhythmic Drugs for Atrial Fibrillation.新型抗心律失常药物治疗心房颤动。
Int J Mol Sci. 2022 Apr 7;23(8):4096. doi: 10.3390/ijms23084096.
细胞死亡研究的十年:为细胞坏死作用带来新的生命。
Pharmacol Ther. 2021 Apr;220:107717. doi: 10.1016/j.pharmthera.2020.107717. Epub 2020 Oct 24.
4
Mir-30d Regulates Cardiac Remodeling by Intracellular and Paracrine Signaling.miR-30d 通过细胞内和旁分泌信号调节心脏重塑。
Circ Res. 2021 Jan 8;128(1):e1-e23. doi: 10.1161/CIRCRESAHA.120.317244. Epub 2020 Oct 22.
5
TRPM4 non-selective cation channel in human atrial fibroblast growth.TRPM4 非选择性阳离子通道在人心房成纤维细胞生长中的作用。
Pflugers Arch. 2020 Dec;472(12):1719-1732. doi: 10.1007/s00424-020-02476-0. Epub 2020 Oct 13.
6
ER Stress-Induced Secretion of Proteins and Their Extracellular Functions in the Heart.内质网应激诱导的心脏蛋白质分泌及其细胞外功能。
Cells. 2020 Sep 10;9(9):2066. doi: 10.3390/cells9092066.
7
Emerging connectivity of programmed cell death pathways and its physiological implications.程序性细胞死亡途径的新兴连接及其生理意义。
Nat Rev Mol Cell Biol. 2020 Nov;21(11):678-695. doi: 10.1038/s41580-020-0270-8. Epub 2020 Sep 1.
8
Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF.沙库巴曲缬沙坦对 HFpEF 患者细胞外基质调节生物标志物的影响。
J Am Coll Cardiol. 2020 Aug 4;76(5):503-514. doi: 10.1016/j.jacc.2020.05.072.
9
Intracellular calcium leak in heart failure and atrial fibrillation: a unifying mechanism and therapeutic target.心力衰竭和心房颤动中的细胞内钙泄漏:一种统一的机制和治疗靶点。
Nat Rev Cardiol. 2020 Nov;17(11):732-747. doi: 10.1038/s41569-020-0394-8. Epub 2020 Jun 18.
10
Cardiac Fibroblast Diversity.心肌成纤维细胞多样性。
Annu Rev Physiol. 2020 Feb 10;82:63-78. doi: 10.1146/annurev-physiol-021119-034527.